Osgentide: a rational drug candidate for dual-targeting treatment of bone-metabolic diseasesWANG De-xin, HAN Xiang, LIN Hao, YANG Xiao-xiao, FENG He-he3-6,11
Comparative analysis for the institutions of the adulterated and misbranded drug in China and USADING Jin-xi, LIU Xiao7-11
Requirements for marketing authorization of antiretroviral drugsLI Ya-jie, SHAO Ying, ZHAO De-heng17-20
Progress in the research and development of medicines and vaccines for HIV/AIDs and related diseasesDU Hai-zhou, SONG Jin-yan, WANG Tian-jin, CAO Yong-mei25-30,34
Advance on drugs emerging targets in the HIV replication cycleLIU Jing, WEI Jian-an, SONG Chun-xin31-34
Efficacy and safety of cetirizine-pseudoephedrine sustained-release tablets in the treatment of seasonal and perennial allergic rhinitisLOU Xiao-feng, WANG De-hui, HU Xian-yue, Huang Xiu-qing, HE Zhen-yu, ZHENG Wang-sheng43-46,52